Transce3nd’s Teladoc Health TDOC Stock Holding History

Transce3nd’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23	Closed	-$200	–	1045
2025 Q2	$200	Hold	23	–	–	﹤0.01%	1161
2025 Q1	$183	Hold	23	–	–	﹤0.01%	1134
2024 Q4	$209	Buy	+23	New	+$222	﹤0.01%	1457

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Transce3nd's TDOC Position: Q3 2025 in Review

Transce3nd sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 23 shares — an estimated $200 sold.

Transce3nd first reported a position in TDOC in Q4 2024 and held it in 3 quarters. The position peaked at $209 in Q4 2024. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

Transce3nd reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 23 Teladoc Health shares in Q3 2025, an estimated $200.
Transce3nd first reported a position in Teladoc Health in Q4 2024 and held it in 3 quarters.
Transce3nd's Teladoc Health position peaked at $209 in Q4 2024.
355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.